{"id":4369,"date":"2025-08-11T16:06:10","date_gmt":"2025-08-11T16:06:10","guid":{"rendered":"https:\/\/qelizaesthetics.com\/?p=4369"},"modified":"2025-08-11T16:06:12","modified_gmt":"2025-08-11T16:06:12","slug":"the-power-of-zone-2-training-shred-fat-live-longer","status":"publish","type":"post","link":"https:\/\/qelizaesthetics.com\/sq\/fuqia-e-stervitjes-ne-zonen-2-copetoni-dhjamin-jetoni-me-gjate\/","title":{"rendered":"Fuqia e Trajnimit t\u00eb Zon\u00ebs 2: Shk\u00ebputni Dhjamin dhe Jetoni M\u00eb Gjat\u00eb"},"content":{"rendered":"

N\u00eb MOOV Utah, ne integrojm\u00eb strategji t\u00eb bazuara n\u00eb prova p\u00ebr t\u00eb p\u00ebrmir\u00ebsuar sh\u00ebndetin metabolik, jet\u00ebgjat\u00ebsin\u00eb,
dhe performanc\u00ebn. Nj\u00eb nga qasjet themelore q\u00eb p\u00ebrdorim \u00ebsht\u00eb trajnimi i Zon\u00ebs 2, nj\u00eb
metod\u00eb efektive p\u00ebr p\u00ebrmir\u00ebsimin e VO2 max dhe p\u00ebrshpejtimin e humbjes s\u00eb yndyr\u00ebs. Kur shoq\u00ebrohet me t\u00eb p\u00ebrshtatura
suplemente dhe terapi t\u00eb avancuara si agonist\u00ebt e receptorit GLP-1 (Ozempic dhe Tirzepatide),
rezultatet jan\u00eb t\u00eb jasht\u00ebzakonshme.
Ky studim rasti detajon progresin e nj\u00eb klienti 30-vje\u00e7ar i cili pa p\u00ebrmir\u00ebsime t\u00eb konsiderueshme n\u00eb p\u00ebrb\u00ebrjen e trupit dhe gjendjen fizike kardiovaskulare p\u00ebrmes nj\u00eb plani t\u00eb personalizuar q\u00eb integronte k\u00ebta element\u00eb.<\/em><\/p>\n\n\n\n

Pse Trajnimi i Zon\u00ebs 2 \u00ebsht\u00eb thelb\u00ebsor<\/h3>\n\n\n\n

St\u00ebrvitja e Zon\u00ebs 2 p\u00ebrfshin ushtrime n\u00eb 60-70% t\u00eb rrahjeve maksimale t\u00eb zemr\u00ebs, nj\u00eb diapazon q\u00eb kryesisht
djeg dhjamin si l\u00ebnd\u00eb djeg\u00ebse. Kjo metod\u00eb p\u00ebrmir\u00ebson funksionin mitokondrial, rrit efikasitetin aerobik dhe
promovon humbjen e q\u00ebndrueshme t\u00eb yndyr\u00ebs. N\u00eb MOOV Utah, ne fillojm\u00eb duke vler\u00ebsuar VO2 max p\u00ebr t\u00eb ndihmuar klient\u00ebt
p\u00ebrcaktojn\u00eb diapazonin e tyre aktual t\u00eb Zon\u00ebs 2. N\u00eb k\u00ebt\u00eb rast, Zona 2 e llogaritur e klientit bazuar n\u00eb mosh\u00eb ishte 119-133 rrahje n\u00eb minut\u00eb, por testimi zbuloi se Zona e tij aktuale 2 ishte duksh\u00ebm m\u00eb e ul\u00ebt. St\u00ebrvitja n\u00eb diapazonin e llogaritur do ta kishte vendosur at\u00eb n\u00eb Zon\u00ebn 3, e cila nuk ofron t\u00eb nevojshmet.
p\u00ebrshtatje p\u00ebr humbjen e yndyr\u00ebs ose p\u00ebrmir\u00ebsimin e kapacitetit aerobik, dhe do ta kishte vonuar ndjesh\u00ebm
p\u00ebrparim.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

Progresi dhe Rregullimet e Klientit
Strategjia Fillestare (Janar 2024):<\/h3>\n\n\n\n

Duke pasur parasysh obezitetin e tij morbid dhe gjendjen aerobe t\u00eb dekondicionuar, s\u00eb bashku me nj\u00eb VO2 max shum\u00eb t\u00eb ul\u00ebt p\u00ebr
n\u00eb mosh\u00ebn e tij, ne u p\u00ebrqendruam n\u00eb nd\u00ebrtimin e nj\u00eb baze kardiovaskulare p\u00ebrmes trajnimit ekskluziv t\u00eb Zon\u00ebs 2. Ne
i k\u00ebshilloi klientit t\u00eb angazhohej n\u00eb 30-60 minuta ushtrime t\u00eb Zon\u00ebs 2 (ecje, \u00e7ikliz\u00ebm ose p\u00ebrdorim t\u00eb nj\u00eb
eliptik) 3-5 dit\u00eb n\u00eb jav\u00eb. Ai gjithashtu filloi nj\u00eb regjim me doz\u00eb t\u00eb ul\u00ebt Tirzepatide n\u00eb janar 2024 p\u00ebr t\u00eb
mb\u00ebshtesin ngopjen dhe humbjen e yndyr\u00ebs. Deri n\u00eb muajin e pest\u00eb, ai e kishte rritur doz\u00ebn n\u00eb nj\u00eb doz\u00eb maksimale prej 5 mg
\u00e7do jav\u00eb para se t\u00eb filloni nj\u00eb ulje graduale, aktualisht duke u ulur n\u00eb 4.5 mg n\u00eb jav\u00eb, bazuar n\u00eb
humbje peshe dhe ngopje. K\u00ebto p\u00ebrfaq\u00ebsojn\u00eb doza relativisht t\u00eb ul\u00ebta t\u00eb agonist\u00ebve GLP-1 p\u00ebr gati 70.
kilogram\u00eb humbje peshe t\u00eb arritura gjat\u00eb n\u00ebnt\u00eb muajve.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

Ndryshimet n\u00eb P\u00ebrb\u00ebrjen e Trupit (Janar 2024 \u2013 Tetor 2024):<\/h3>\n\n\n\n

Kjo qasje gjith\u00ebp\u00ebrfshir\u00ebse rezultoi n\u00eb r\u00ebnien e pesh\u00ebs s\u00eb klientit nga 272 lbs n\u00eb janar.
2024 deri n\u00eb 90 kg deri n\u00eb tetor 2024 - nj\u00eb humbje e jasht\u00ebzakonshme prej mbi 65 kg me humbje minimale t\u00eb muskujve.
N\u00eb korrik 2024, filluam t\u00eb gjurmojm\u00eb mas\u00ebn dhjamore viscerale (e padisponueshme m\u00eb par\u00eb p\u00ebr k\u00ebt\u00eb klient) dhe vum\u00eb re
nj\u00eb ulje prej 25% n\u00eb v\u00ebllimin e yndyr\u00ebs viscerale nga korriku n\u00eb tetor. Ulja e yndyr\u00ebs viscerale, e cila \u00ebsht\u00eb
e lidhur me s\u00ebmundjet metabolike, pati ndikim t\u00eb r\u00ebnd\u00ebsish\u00ebm n\u00eb sh\u00ebndetin e tij t\u00eb p\u00ebrgjithsh\u00ebm. Humbja e muskujve ishte
minimizohet m\u00eb tej me shtimin e sermorelin\u00ebs.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

P\u00ebrmir\u00ebsimet e P\u00ebrparimit Maksimal t\u00eb VO2 dhe St\u00ebrvitjes<\/h3>\n\n\n\n

\u2022 Dhjetor 2023 (270 lbs): VO2 max prej 31
\u2022 Qershor 2024 (230 lbs): VO2 max prej 37
\u2022 Tetor 2024 (90 kg): VO2 maks. 43<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

Ne e filluam programin me trajnimin 100% Zona 2 dhe m\u00eb von\u00eb p\u00ebrfshim\u00eb nj\u00eb ndarje 90\/10 midis
N\u00eb Zon\u00ebn 2 dhe Zon\u00ebn 4, klienti arriti nj\u00eb rritje mbres\u00ebl\u00ebn\u00ebse t\u00eb VO2 max n\u00eb 43 deri n\u00eb tetor 2024.<\/p>\n\n\n\n

Ndikimi n\u00eb rrezikun e vdekshm\u00ebris\u00eb nga t\u00eb gjitha shkaqet<\/h3>\n\n\n\n

Hulumtimet tregojn\u00eb vazhdimisht se p\u00ebrmir\u00ebsimet n\u00eb VO2 max jan\u00eb t\u00eb lidhura fort me uljen e t\u00eb gjitha-
shkaktojn\u00eb vdekshm\u00ebri. Studimet sugjerojn\u00eb se \u00e7do rritje prej 1 MET n\u00eb VO2 max korrespondon me nj\u00eb rritje prej 10-
Ulje e rrezikut t\u00eb vdekshm\u00ebris\u00eb nga t\u00eb gjitha shkaqet e 15%.
Konvertimi i VO2 Max n\u00eb MET:
1 MET = 3.5 mL\/kg\/min e VO2
\u2022 VO2 maksimale fillestare: 31 mL\/kg\/min
\u2022 VO2 maks. p\u00ebrfundimtar: 43 mL\/kg\/min<\/p>\n\n\n\n

Kjo rritje rezulton n\u00eb nj\u00eb p\u00ebrmir\u00ebsim t\u00eb llogaritur prej 3.43 MET. Bazuar n\u00eb k\u00ebt\u00eb, ulja e
rreziku i vdekshm\u00ebris\u00eb varion nga 34.3% n\u00eb 51.5%.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n

Ulja e rrezikut p\u00ebr s\u00ebmundjet kardiovaskulare, diabetin, hipertensionin dhe kancerin<\/h3>\n\n\n\n

Rritja e VO2 max gjithashtu uli ndjesh\u00ebm rrezikun e klientit p\u00ebr s\u00ebmundje t\u00eb ndryshme:
\u2022 Rreziku i s\u00ebmundjeve kardiovaskulare: I ulur me 51.5% n\u00eb 102.9% (duke v\u00ebn\u00eb re se nj\u00eb >100%
reduktimi \u00ebsht\u00eb i pamundur, por kjo tregon p\u00ebrfitimet e thella).
\u2022 Rreziku i diabetit t\u00eb tipit 2: I ulur me 24% n\u00eb 34.3%.
\u2022 Rreziku i hipertensionit: I reduktuar me 41.2%.
\u2022 Rreziku i vdekshm\u00ebris\u00eb nga kanceri: I ulur me 17.2% n\u00eb 34.3%.<\/p>\n\n\n\n

Reduktimi i dhjamit visceral dhe ndikimet e tij n\u00eb sh\u00ebndet<\/h3>\n\n\n\n

Nd\u00ebrsa t\u00eb dh\u00ebnat e yndyr\u00ebs viscerale nuk ishin t\u00eb disponueshme n\u00eb fillim t\u00eb programit, ne vler\u00ebsojm\u00eb se klienti
p\u00ebrjetuan mbi nj\u00eb reduktim prej 50% n\u00eb mas\u00ebn e yndyr\u00ebs viscerale. Objektivisht, ne mat\u00ebm nj\u00eb reduktim prej 25%
ulje nga korriku n\u00eb tetor 2024, e cila ka p\u00ebrfitime t\u00eb konsiderueshme sh\u00ebndet\u00ebsore, duke p\u00ebrfshir\u00eb nj\u00eb 20-30%
ulje e rrezikut t\u00eb s\u00ebmundjeve kardiovaskulare, p\u00ebrmir\u00ebsim i sh\u00ebndetit arterial dhe lipide m\u00eb t\u00eb favorshme
profile.<\/p>\n\n\n\n

P\u00ebrmbledhje e ndikimeve sh\u00ebndet\u00ebsore nga nj\u00eb reduktim i dhjamit visceral me 25%:<\/h3>\n\n\n\n

\u2022 Rreziku i s\u00ebmundjeve kardiovaskulare: I reduktuar me 20-30%
\u2022 Rreziku i diabetit t\u00eb tipit 2: I reduktuar me 20-30%
\u2022 Rreziku i sindrom\u00ebs metabolike: I reduktuar me 20-25%
\u2022 Presioni i gjakut: I ulur me 5-8 mmHg sistolik, 3-5 mmHg diastolik
\u2022 Sh\u00ebnjues inflamator\u00eb: T\u00eb reduktuar me 15-20%
\u2022 Rreziku i kancerit: I reduktuar me 15-20%
\u2022 Rreziku i NAFLD (s\u00ebmundja e m\u00ebl\u00e7is\u00eb yndyrore joalkoolike): I reduktuar me 20-30%
\u2022 Ekuilibri hormonal: P\u00ebrmir\u00ebsuar nga 20-25%
\u2022 Rreziku i r\u00ebnies njoh\u00ebse: I reduktuar me 15-20%<\/p>\n\n\n\n

N\u00eb MOOV Utah, p\u00ebrdorimi yn\u00eb i testimit VO2 max dhe trajnimit specifik t\u00eb rrahjeve t\u00eb zemr\u00ebs i lejoi k\u00ebtij klienti
p\u00ebr t\u00eb arritur rezultate transformuese me nj\u00eb plan t\u00eb thjesht\u00eb dhe t\u00eb zbatuesh\u00ebm. P\u00ebrmir\u00ebsimet e tij n\u00eb VO2 max
kan\u00eb \u00e7uar n\u00eb nj\u00eb ulje t\u00eb ndjeshme t\u00eb rrezikut t\u00eb vdekjes nga shkaqe t\u00eb ndryshme. Edhe n\u00eb rast t\u00eb
d\u00ebmtimi traumatik, gjendja e tij e p\u00ebrmir\u00ebsuar fizike do t\u00eb p\u00ebrmir\u00ebsoj\u00eb shanset e mbijetes\u00ebs dhe sh\u00ebrimit. Rreziku i tij
mund\u00ebsia e zhvillimit t\u00eb diabetit dhe hipertensionit \u00ebsht\u00eb ulur ndjesh\u00ebm, dhe sh\u00ebndeti i tij i p\u00ebrgjithsh\u00ebm \u00ebsht\u00eb
p\u00ebrmir\u00ebsuar jasht\u00ebzakonisht.<\/p>\n\n\n\n

\u2026\u2026 ...<\/p>\n\n\n\n

Referencat<\/h3>\n\n\n\n

1. Ross R. et al., Vler\u00ebsimi i gjendjes fizike kardiorespiratore n\u00eb praktik\u00ebn klinike, 653-699.
2. Brewer CP et al., Efekti i Ngarkes\u00ebs s\u00eb Fosfatit t\u00eb Natriumit n\u00eb Maj\u00ebn e VO2, 187-194.
3. Kuwabara AM et al., Mungesa e hekurit tek atlet\u00ebt, 620-642.
4. Perez JM et al., Efektet e l\u00ebngut t\u00eb panxharit n\u00eb VO2 Max, 332-342.
5. Antunes BM et al., Cil\u00ebsia dhe Koh\u00ebzgjatja e Gjumit e Lidhur me Performanc\u00ebn, 252-256.
6. Berge J. et al., Fitnesi Kardiorespirator dhe Humbja e Peshes n\u00eb Obezitetin e R\u00ebnd\u00eb, 69.
7. Forman DE et al., Testimi i Ushtrimit Kardiopulmonar, 68-86.
8. Buckley JD et al., Acidet yndyrore t\u00eb pangopura Omega-3 me zinxhir t\u00eb gjat\u00eb p\u00ebr reduktimin e obezitetit, 1212-1230.
9. Tabrizi R. et al., Efektet e Marrjes s\u00eb Kafein\u00ebs n\u00eb Humbjen e Peshes, 2688-2696.<\/p>","protected":false},"excerpt":{"rendered":"

At MOOV Utah, we integrate evidence-based strategies to enhance metabolic health, longevity,and performance. One of the cornerstone approaches we employ is Zone 2 training, a highlyeffective method for improving VO2 max and accelerating fat loss. When paired with tailoredsupplementation and advanced therapies like GLP-1 receptor agonists (Ozempic & Tirzepatide),the results are remarkable.This case study details […]<\/p>","protected":false},"author":1,"featured_media":4370,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-4369","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/qelizaesthetics.com\/sq\/wp-json\/wp\/v2\/posts\/4369","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/qelizaesthetics.com\/sq\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/qelizaesthetics.com\/sq\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/qelizaesthetics.com\/sq\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/qelizaesthetics.com\/sq\/wp-json\/wp\/v2\/comments?post=4369"}],"version-history":[{"count":1,"href":"https:\/\/qelizaesthetics.com\/sq\/wp-json\/wp\/v2\/posts\/4369\/revisions"}],"predecessor-version":[{"id":4371,"href":"https:\/\/qelizaesthetics.com\/sq\/wp-json\/wp\/v2\/posts\/4369\/revisions\/4371"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/qelizaesthetics.com\/sq\/wp-json\/wp\/v2\/media\/4370"}],"wp:attachment":[{"href":"https:\/\/qelizaesthetics.com\/sq\/wp-json\/wp\/v2\/media?parent=4369"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/qelizaesthetics.com\/sq\/wp-json\/wp\/v2\/categories?post=4369"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/qelizaesthetics.com\/sq\/wp-json\/wp\/v2\/tags?post=4369"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}